Publication | Closed Access

Developmental toxicity of carbendazim: comparison of no-observed-adverse-effect level and benchmark dose approach

Benchmark Dose ApproachDevelopmental ToxicologyPharmacologyNo-observed-adverse-effect LevelToxicologyPharmacotherapyEcotoxicologyDevelopmental ToxicityToxicological AspectExperimental ToxicologyMedicineClinical ToxicologyToxicological MechanismDrug Discovery